APO Research
Talk to an analyst

APO RESEARCH · REPORT

Poliovirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Poliovirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025187 pages

Choose your research edition.

Industry ResearchPoliovirus Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Poliovirus Vaccine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Poliovirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poliovirus Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Poliovirus Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Poliovirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Poliovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Poliovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poliovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Poliovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Poliovirus Vaccine include Sanofi, GSK, Tiantan Biological, Serum Institute, Panacea Biotec Ltd, IMBCA, Halfkin Bio-Pharmaceuticals, Bio-Med and Bibcol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Poliovirus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Poliovirus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Poliovirus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Poliovirus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Poliovirus Vaccine Segment by Company

Sanofi

GSK

Tiantan Biological

Serum Institute

Panacea Biotec Ltd

IMBCA

Halfkin Bio-Pharmaceuticals

Bio-Med

Bibcol

Poliovirus Vaccine Segment by Type

Inactivated Polio Vaccine (IPV)

Oral Polio Vaccine (OPV)

Poliovirus Vaccine Segment by Application

Public

Private

Poliovirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poliovirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poliovirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poliovirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Poliovirus Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Poliovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Poliovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Poliovirus Vaccine Industry Trends Table 2. Poliovirus Vaccine Industry Drivers Table 3. Poliovirus Vaccine Industry Opportunities and Challenges Table 4. Poliovirus Vaccine Industry Restraints Table 5. Global Poliovirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Poliovirus Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Poliovirus Vaccine Sales Market Share by Manufacturers Table 9. Global Poliovirus Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Poliovirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Poliovirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Poliovirus Vaccine Manufacturers, Product Type & Application Table 13. Global Poliovirus Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Poliovirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inactivated Polio Vaccine (IPV) Table 17. Major Manufacturers of Oral Polio Vaccine (OPV) Table 18. Global Poliovirus Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Poliovirus Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Poliovirus Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Poliovirus Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Poliovirus Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Poliovirus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Poliovirus Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Poliovirus Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Poliovirus Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Poliovirus Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Public Table 29. Major Manufacturers of Private Table 30. Global Poliovirus Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Poliovirus Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Poliovirus Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Poliovirus Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Poliovirus Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Poliovirus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Poliovirus Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Poliovirus Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Poliovirus Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Poliovirus Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Poliovirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Poliovirus Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Poliovirus Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Poliovirus Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Poliovirus Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Poliovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Poliovirus Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Poliovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Poliovirus Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Poliovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Poliovirus Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Poliovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Poliovirus Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Poliovirus Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Poliovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Poliovirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Poliovirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Poliovirus Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Poliovirus Vaccine Revenue Market Share by Region (2027-2032) Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sanofi Poliovirus Vaccine Product Portfolio Table 66. Sanofi Recent Development Table 67. GSK Company Information Table 68. GSK Business Overview Table 69. GSK Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. GSK Poliovirus Vaccine Product Portfolio Table 71. GSK Recent Development Table 72. Tiantan Biological Company Information Table 73. Tiantan Biological Business Overview Table 74. Tiantan Biological Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Tiantan Biological Poliovirus Vaccine Product Portfolio Table 76. Tiantan Biological Recent Development Table 77. Serum Institute Company Information Table 78. Serum Institute Business Overview Table 79. Serum Institute Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Serum Institute Poliovirus Vaccine Product Portfolio Table 81. Serum Institute Recent Development Table 82. Panacea Biotec Ltd Company Information Table 83. Panacea Biotec Ltd Business Overview Table 84. Panacea Biotec Ltd Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio Table 86. Panacea Biotec Ltd Recent Development Table 87. IMBCA Company Information Table 88. IMBCA Business Overview Table 89. IMBCA Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. IMBCA Poliovirus Vaccine Product Portfolio Table 91. IMBCA Recent Development Table 92. Halfkin Bio-Pharmaceuticals Company Information Table 93. Halfkin Bio-Pharmaceuticals Business Overview Table 94. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio Table 96. Halfkin Bio-Pharmaceuticals Recent Development Table 97. Bio-Med Company Information Table 98. Bio-Med Business Overview Table 99. Bio-Med Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Bio-Med Poliovirus Vaccine Product Portfolio Table 101. Bio-Med Recent Development Table 102. Bibcol Company Information Table 103. Bibcol Business Overview Table 104. Bibcol Poliovirus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Bibcol Poliovirus Vaccine Product Portfolio Table 106. Bibcol Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Poliovirus Vaccine Distributors List Table 110. Poliovirus Vaccine Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Poliovirus Vaccine Product Image Figure 2. Global Poliovirus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poliovirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Poliovirus Vaccine Sales (2021-2032) & (k units) Figure 5. Global Poliovirus Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Poliovirus Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inactivated Polio Vaccine (IPV) Image Figure 9. Oral Polio Vaccine (OPV) Image Figure 10. Global Poliovirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Poliovirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Poliovirus Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Poliovirus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Poliovirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Poliovirus Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Public Image Figure 17. Private Image Figure 18. Global Poliovirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Poliovirus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Poliovirus Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Poliovirus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Poliovirus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Poliovirus Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Poliovirus Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Poliovirus Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Poliovirus Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Poliovirus Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Poliovirus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Poliovirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Poliovirus Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Poliovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Poliovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Poliovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Poliovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Poliovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Poliovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Poliovirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Poliovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Poliovirus Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Poliovirus Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Polio Vaccine (IPV)
  • Oral Polio Vaccine (OPV)
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • GSK
  • Tiantan Biological
  • Serum Institute
  • Panacea Biotec Ltd
  • IMBCA
  • Halfkin Bio-Pharmaceuticals
  • Bio-Med
  • Bibcol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Poliovirus Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Poliovirus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Poliovirus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Poliovirus Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Poliovirus Vaccine Market Dynamics
  1. 2.1 Poliovirus Vaccine Industry Trends
  2. 2.2 Poliovirus Vaccine Industry Drivers
  3. 2.3 Poliovirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Poliovirus Vaccine Industry Restraints
3 Poliovirus Vaccine Market by Manufacturers
  1. 3.1 Global Poliovirus Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Poliovirus Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Poliovirus Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Poliovirus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Poliovirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Poliovirus Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Poliovirus Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Poliovirus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Poliovirus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Poliovirus Vaccine Tier 1, Tier 2, and Tier 3
4 Poliovirus Vaccine Market by Type
  1. 4.1 Poliovirus Vaccine Type Introduction
  2. 4.1.1 Inactivated Polio Vaccine (IPV)
  3. 4.1.2 Oral Polio Vaccine (OPV)
  4. 4.2 Global Poliovirus Vaccine Sales by Type
  5. 4.2.1 Global Poliovirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Poliovirus Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Poliovirus Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Poliovirus Vaccine Revenue by Type
  9. 4.3.1 Global Poliovirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Poliovirus Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Poliovirus Vaccine Revenue Market Share by Type (2021-2032)
5 Poliovirus Vaccine Market by Application
  1. 5.1 Poliovirus Vaccine Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Poliovirus Vaccine Sales by Application
  5. 5.2.1 Global Poliovirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Poliovirus Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Poliovirus Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Poliovirus Vaccine Revenue by Application
  9. 5.3.1 Global Poliovirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Poliovirus Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Poliovirus Vaccine Revenue Market Share by Application (2021-2032)
6 Global Poliovirus Vaccine Sales by Region
  1. 6.1 Global Poliovirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Poliovirus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Poliovirus Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Poliovirus Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Poliovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Poliovirus Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Poliovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Poliovirus Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Poliovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Poliovirus Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Poliovirus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Poliovirus Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Poliovirus Vaccine Revenue by Region
  1. 7.1 Global Poliovirus Vaccine Revenue by Region
  2. 7.1.1 Global Poliovirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Poliovirus Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Poliovirus Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Poliovirus Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Poliovirus Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Poliovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Poliovirus Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Poliovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Poliovirus Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Poliovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Poliovirus Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Poliovirus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Poliovirus Vaccine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Poliovirus Vaccine Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Tiantan Biological
  14. 8.3.1 Tiantan Biological Company Information
  15. 8.3.2 Tiantan Biological Business Overview
  16. 8.3.3 Tiantan Biological Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tiantan Biological Poliovirus Vaccine Product Portfolio
  18. 8.3.5 Tiantan Biological Recent Developments
  19. 8.4 Serum Institute
  20. 8.4.1 Serum Institute Company Information
  21. 8.4.2 Serum Institute Business Overview
  22. 8.4.3 Serum Institute Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute Poliovirus Vaccine Product Portfolio
  24. 8.4.5 Serum Institute Recent Developments
  25. 8.5 Panacea Biotec Ltd
  26. 8.5.1 Panacea Biotec Ltd Company Information
  27. 8.5.2 Panacea Biotec Ltd Business Overview
  28. 8.5.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Panacea Biotec Ltd Poliovirus Vaccine Product Portfolio
  30. 8.5.5 Panacea Biotec Ltd Recent Developments
  31. 8.6 IMBCA
  32. 8.6.1 IMBCA Company Information
  33. 8.6.2 IMBCA Business Overview
  34. 8.6.3 IMBCA Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IMBCA Poliovirus Vaccine Product Portfolio
  36. 8.6.5 IMBCA Recent Developments
  37. 8.7 Halfkin Bio-Pharmaceuticals
  38. 8.7.1 Halfkin Bio-Pharmaceuticals Company Information
  39. 8.7.2 Halfkin Bio-Pharmaceuticals Business Overview
  40. 8.7.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Portfolio
  42. 8.7.5 Halfkin Bio-Pharmaceuticals Recent Developments
  43. 8.8 Bio-Med
  44. 8.8.1 Bio-Med Company Information
  45. 8.8.2 Bio-Med Business Overview
  46. 8.8.3 Bio-Med Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Med Poliovirus Vaccine Product Portfolio
  48. 8.8.5 Bio-Med Recent Developments
  49. 8.9 Bibcol
  50. 8.9.1 Bibcol Company Information
  51. 8.9.2 Bibcol Business Overview
  52. 8.9.3 Bibcol Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bibcol Poliovirus Vaccine Product Portfolio
  54. 8.9.5 Bibcol Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Poliovirus Vaccine Value Chain Analysis
  2. 9.1.1 Poliovirus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Poliovirus Vaccine Production Mode & Process
  6. 9.2 Poliovirus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Poliovirus Vaccine Distributors
  9. 9.2.3 Poliovirus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst